Back to search

Article

Validation and clinical evaluation of a comprehensive circulating tumor DNA assay for genomic profiling in solid tumors

2025-10-03

Abstract excerpt

<title>Abstract</title> <p>Background Since 2023, the Department of Pathology at Vienna General Hospital has implemented comprehensive genomic profiling (CGP) of circulating tumor DNA (ctDNA) using the AmoyDx® Comprehensive Assay, Initially intended for cases where tissue biopsy was unfeasible, this study summarizes the analytical validation, biomarker yield, and retrospective clinical utility of this assay. Meth...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1cf94001-92e4-5913-b12f-9233cfe85aa9
DOI
10.21203/rs.3.rs-7479442/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Validation and clinical evaluation of a comprehensive circulating tumor DNA assay for genomic profiling in solid tumorsDOI 10.21203/rs.3.rs-7479442/v1
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint ReviewSemantic proximity
A clinician's handbook for using ctDNA throughout the patient journey.Semantic proximity
Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors.Semantic proximity
Cell-Free DNA, Tumor Molecular Concordance, and Clinical Correlates of Patients with Cancer Treated in a Large Community Health Care NetworkSemantic proximity
Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study.Semantic proximity
Analytical Performance Evaluation of a 523-Gene Circulating Tumor DNA Assay for Next-Generation Sequencing-Based Comprehensive Tumor Profiling in Liquid Biopsy Samples.Semantic proximity
Concurrent Tissue and Circulating Tumor DNA Molecular Profiling to Detect Guideline-Based Targeted Mutations in a Multicancer Cohort.Semantic proximity
Analytical and Clinical Validation of Cell-Free Circulating Tumor DNA Assay for the Estimation of Tumor Mutational Burden.Semantic proximity
Analytical validation and clinical utilization of K-4CARE<sup>TM</sup>: a comprehensive genomic profiling assay with personalized MRD detectionSemantic proximity
Clinical Circulating Tumor DNA Testing for Precision Oncology.Semantic proximity
Clinical Practice Guideline for Blood-based Circulating Tumor DNA Assays.Semantic proximity
Genetic profiling of cancer with circulating tumor DNA analysis.Semantic proximity
Select a neighboring publication to make it the new centre.